Compared with the wild-type genotypes of CYP1B1 rs1056827 (CC), the homozygous variant genotypes (AA) showed a significantly higher risk in breast cancer, yielding an OR of 6.90 (95% CI = 1.50–31.76). This evidence concerns the gene CYP1B1 and breast carcinoma.